Shandong Weigao Medical Polymer Cash on Hand 2012-2024 | SHWGF

Shandong Weigao Medical Polymer cash on hand from 2012 to 2024. Cash on hand can be defined as cash deposits at financial institutions that can immediately be withdrawn at any time, and investments maturing in one year or less that are highly liquid and therefore regarded as cash equivalents and reported with or near cash line items.

Shandong Weigao Medical Polymer Cash on Hand 2012-2024 | SHWGF

Shandong Weigao Medical Polymer cash on hand from 2012 to 2024. Cash on hand can be defined as cash deposits at financial institutions that can immediately be withdrawn at any time, and investments maturing in one year or less that are highly liquid and therefore regarded as cash equivalents and reported with or near cash line items.
Related Stocks
Company NameMarket
Cap
Abbott Laboratories (ABT)$205.7B
Stryker (SYK)$140B
Boston Scientific (BSX)$123.1B
Medtronic (MDT)$115.5B
EssilorLuxottica (ESLOY)$107.3B
Lonza Group Ag (LZAGY)$45.5B
Haleon (HLN)$44B
GE HealthCare Technologies (GEHC)$39.7B
ResMed (RMD)$35.9B
Terumo (TRUMY)$28.3B
Koninklijke Philips (PHG)$24.9B
Zimmer Biomet Holdings (ZBH)$21.4B
Baxter (BAX)$18.3B
Insulet (PODD)$16.5B
Smith & Nephew SNATS (SNN)$11B
Bio-Rad Laboratories (BIO)$10.3B
BellRing Brands (BRBR)$8.6B
Demant (WILYY)$8.4B
Lantheus Holdings (LNTH)$7.5B
ICU Medical (ICUI)$4.2B
TG Therapeutics (TGTX)$4.2B
Prestige Consumer Healthcare (PBH)$3.7B
Haemonetics (HAE)$3.7B
Envista Holdings (NVST)$3.6B
Perrigo (PRGO)$3.6B
Neogen (NEOG)$3.1B
GN Store Nord (GNNDY)$3B
QuidelOrtho (QDEL)$2.6B
Agios Pharmaceuticals (AGIO)$2.6B
Green Thumb Industries (GTBIF)$2.2B